Ryan Specialty (RYAN) Projected to Release Earnings on Thursday

Ryan Specialty (NYSE:RYANGet Free Report) is projected to announce its Q2 2026 results after the market closes on Thursday, July 30th. Analysts expect Ryan Specialty to announce earnings of $0.61 per share and revenue of $873.93 million for the quarter. Individuals may visit the the company’s upcoming Q2 2026 earning summary page for the latest details on the call scheduled for Thursday, July 30, 2026 at 4:45 PM ET.

Ryan Specialty (NYSE:RYANGet Free Report) last issued its quarterly earnings data on Thursday, April 30th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. The company had revenue of $795.23 million for the quarter, compared to analysts’ expectations of $781.44 million. Ryan Specialty had a net margin of 8.21% and a return on equity of 41.33%. Ryan Specialty’s revenue for the quarter was up 15.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.39 earnings per share. On average, analysts expect Ryan Specialty to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Ryan Specialty Stock Performance

NYSE RYAN opened at $43.21 on Tuesday. The company has a market capitalization of $11.39 billion, a price-to-earnings ratio of 56.11, a PEG ratio of 0.91 and a beta of 0.61. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 2.90. Ryan Specialty has a twelve month low of $29.28 and a twelve month high of $66.25. The stock has a fifty day simple moving average of $36.78 and a 200 day simple moving average of $38.50.

Ryan Specialty announced that its Board of Directors has authorized a stock repurchase plan on Tuesday, May 26th that authorizes the company to repurchase $300.00 million in shares. This repurchase authorization authorizes the company to buy up to 3.5% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s management believes its stock is undervalued.

Ryan Specialty Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, May 26th. Stockholders of record on Tuesday, May 12th were paid a $0.13 dividend. The ex-dividend date of this dividend was Tuesday, May 12th. This represents a $0.52 annualized dividend and a dividend yield of 1.2%. Ryan Specialty’s dividend payout ratio is presently 67.53%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on the company. Cantor Fitzgerald lifted their price objective on Ryan Specialty from $33.00 to $34.00 and gave the stock a “neutral” rating in a research note on Thursday, July 9th. UBS Group lowered their price target on shares of Ryan Specialty from $52.00 to $50.00 and set a “buy” rating for the company in a report on Wednesday, July 8th. Wolfe Research downgraded shares of Ryan Specialty from an “outperform” rating to a “peer perform” rating in a research report on Thursday, July 9th. Morgan Stanley upped their price objective on shares of Ryan Specialty from $39.00 to $42.00 and gave the company an “overweight” rating in a research note on Monday, July 6th. Finally, Atlantic Securities set a $69.00 price objective on shares of Ryan Specialty in a research report on Wednesday, July 15th. Eight research analysts have rated the stock with a Buy rating, nine have given a Hold rating and two have issued a Sell rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $50.00.

View Our Latest Stock Analysis on Ryan Specialty

Insider Buying and Selling at Ryan Specialty

In other Ryan Specialty news, Chairman Patrick G. Ryan purchased 120,000 shares of the company’s stock in a transaction on Friday, June 5th. The shares were purchased at an average cost of $32.50 per share, with a total value of $3,900,000.00. Following the completion of the purchase, the chairman owned 13,817,859 shares in the company, valued at $449,080,417.50. This represents a 0.88% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director John W. Rogers, Jr. acquired 7,500 shares of Ryan Specialty stock in a transaction dated Wednesday, June 10th. The shares were bought at an average cost of $35.16 per share, with a total value of $263,700.00. Following the transaction, the director owned 117,933 shares in the company, valued at approximately $4,146,524.28. This trade represents a 6.79% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last three months, insiders have acquired 130,715 shares of company stock valued at $4,263,590. 52.03% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Ryan Specialty

A number of large investors have recently bought and sold shares of RYAN. Pacer Advisors Inc. increased its stake in Ryan Specialty by 21.3% in the fourth quarter. Pacer Advisors Inc. now owns 17,988 shares of the company’s stock valued at $929,000 after purchasing an additional 3,155 shares in the last quarter. Invesco Ltd. grew its stake in shares of Ryan Specialty by 34.7% in the 4th quarter. Invesco Ltd. now owns 278,583 shares of the company’s stock valued at $14,383,000 after buying an additional 71,699 shares during the period. Corient Private Wealth LLC grew its stake in shares of Ryan Specialty by 5.0% in the 4th quarter. Corient Private Wealth LLC now owns 17,807 shares of the company’s stock valued at $919,000 after buying an additional 840 shares during the period. Alberta Investment Management Corp bought a new stake in Ryan Specialty in the 4th quarter valued at about $1,373,000. Finally, Vident Advisory LLC increased its position in Ryan Specialty by 11.0% in the 4th quarter. Vident Advisory LLC now owns 5,338 shares of the company’s stock valued at $276,000 after buying an additional 529 shares in the last quarter. 84.82% of the stock is currently owned by institutional investors and hedge funds.

Ryan Specialty Company Profile

(Get Free Report)

Ryan Specialty Group, Inc (NYSE: RYAN) is a global specialty insurance and reinsurance platform that partners with a network of insurers and reinsurers to deliver tailored risk solutions. The company focuses on complex and large-scale risks across multiple industry sectors, leveraging its underwriting expertise to structure coverage programs that meet clients’ unique needs.

Ryan Specialty’s core offerings span a diverse range of specialty lines, including casualty, property, professional liability, marine and energy, program administration, and sports and entertainment.

Read More

Earnings History for Ryan Specialty (NYSE:RYAN)

Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.